These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37091809)

  • 101. Redefining normal breast cell populations using long noncoding RNAs.
    Bitar M; Rivera IS; Almeida I; Shi W; Ferguson K; Beesley J; Lakhani SR; Edwards SL; French JD
    Nucleic Acids Res; 2023 Jul; 51(12):6389-6410. PubMed ID: 37144467
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Alternative splicing variants involved in pyroptosis and cuproptosis contribute to phenotypic remodeling of the tumor microenvironment in cervical cancer.
    Bi K; Yang J; Wei X
    Reprod Sci; 2023 Dec; 30(12):3648-3660. PubMed ID: 37434062
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Pan-cancer analysis of super enhancer-induced PRR7-AS1 as a potential prognostic and immunological biomarker.
    Wang R; Liu N; Li G; Liu J; Ma X; Liu X; Li J
    Front Genet; 2023; 14():1160599. PubMed ID: 37091809
    [No Abstract]   [Full Text] [Related]  

  • 104. A pan-cancer analysis indicates long noncoding RNA HAND2-AS1 as a potential prognostic, immunomodulatory and therapeutic biomarker in various cancers including colorectal adenocarcinoma.
    Samadi P; Shahnazari M; Shekari A; Maghool F; Jalali A
    Cancer Cell Int; 2023 Dec; 23(1):307. PubMed ID: 38042769
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Long non-coding RNA PRR7-AS1 promotes osteosarcoma progression via binding RNF2 to transcriptionally suppress MTUS1.
    Chen-Xi G; Jin-Fu X; An-Quan H; Xiao Y; Ying-Hui W; Suo-Yuan L; Cong S; Tian-Ming Z; Jun S
    Front Oncol; 2023; 13():1227789. PubMed ID: 38033505
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Comprehensive analysis of ZFPM2-AS1 prognostic value, immune microenvironment, drug sensitivity, and co-expression network: from gastric adenocarcinoma to pan-cancers.
    Chen D; Wang M; Jiang X; Xiong Z
    Discov Oncol; 2022 Apr; 13(1):24. PubMed ID: 35416526
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform.
    Shen W; Song Z; Zhong X; Huang M; Shen D; Gao P; Qian X; Wang M; He X; Wang T; Li S; Song X
    Imeta; 2022 Sep; 1(3):e36. PubMed ID: 38868713
    [TBL] [Abstract][Full Text] [Related]  

  • 108. PRR7-AS1 Correlates with Immune Cell Infiltration and Is a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
    Lu Y; Chen S; Wang Q; Zhang J; Pei X
    J Oncol; 2022; 2022():1939368. PubMed ID: 36059812
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Impact of NSCLC metabolic remodeling on immunotherapy effectiveness.
    Lv L; Huang RH; Li J; Xu J; Gao W
    Biomark Res; 2022 Aug; 10(1):66. PubMed ID: 36038935
    [TBL] [Abstract][Full Text] [Related]  

  • 110. HSF1 Stimulates Glutamine Transport by Super-Enhancer-Driven lncRNA LINC00857 in Colorectal Cancer.
    Shen Q; Wang R; Liu X; Song P; Zheng M; Ren X; Ma J; Lu Z; Li J
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010849
    [TBL] [Abstract][Full Text] [Related]  

  • 111. HULC targets the IGF1R-PI3K-AKT axis in trans to promote breast cancer metastasis and cisplatin resistance.
    Zhou L; Li H; Sun T; Wen X; Niu C; Li M; Li W; Hoffman AR; Hu JF; Cui J
    Cancer Lett; 2022 Nov; 548():215861. PubMed ID: 35981570
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA.
    Feng Z; Li K; Qin K; Liang J; Shi M; Ma Y; Zhao S; Liang H; Han D; Shen B; Peng C; Chen H; Jiang L
    J Hematol Oncol; 2022 Aug; 15(1):112. PubMed ID: 35978332
    [TBL] [Abstract][Full Text] [Related]  

  • 113. A novel long noncoding RNA SP100-AS1 induces radioresistance of colorectal cancer via sponging miR-622 and stabilizing ATG3.
    Zhou Y; Shao Y; Hu W; Zhang J; Shi Y; Kong X; Jiang J
    Cell Death Differ; 2023 Jan; 30(1):111-124. PubMed ID: 35978049
    [TBL] [Abstract][Full Text] [Related]  

  • 114. LncRNAs in tumor metabolic reprogramming and immune microenvironment remodeling.
    Yang J; Liu F; Wang Y; Qu L; Lin A
    Cancer Lett; 2022 Sep; 543():215798. PubMed ID: 35738332
    [TBL] [Abstract][Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.